AI-generated summary
The authors reviewed clinical trials and case reports on monochromatic light devices for alopecia areata, gathered from PubMed, Embase, and the Cochrane database. They report that most of the 308-nm excimer laser studies showed hair regrowth and describe the device as safe and effective for refractory scalp and beard AA. Evidence for low-level laser therapy and fractional laser therapy was described as limited and needing more data.
- Who or what was studied
- Patients with alopecia areata, including men, women, and children
- Wavelengths
- 308, 355 nm
- Limits stated in the abstract
- The review includes small clinical trials and case reports, and the authors call for larger, double-blinded trials to compare excimer laser therapy with standard treatments.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Case report. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.